Parkman Healthcare Partners LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001777015

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q3 2023 · 102 positions · Total reported value $545.76M · Top-10 concentration 37.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 68.0% · 26 new · 31 cut · 13 exited

Active Share (vs S&P 500): 97.4% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.8% · vs SPY -4.9% · Prev Value $976.83M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.8% · vs SPY -4.0% · Latest Value $1.11B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2023 13F filing, Parkman Healthcare Partners LLC disclosed 102 equity positions with a combined reported value of $545.76M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 37.3% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2023 were BSX ($31.54M), UTHR ($31.24M), BDX ($25.32M). By sector, the heaviest allocations are Health Care 78.5%, Industrials 2.4%.

Versus the prior quarter, Parkman Healthcare Partners LLC opened 26 new positions, trimmed 31 and fully exited 13, a turnover rate of 68.0% of positions.

The largest new positions opened in Q3 2023 were BSX ($31.54M), UTHR ($31.24M), BDX ($25.32M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2023)

  • BSX BOSTON SCIENTIFIC CORP · $31.54M
  • UTHR UNITED THERAPEUTICS CORP DEL · $31.24M
  • BDX BECTON DICKINSON & CO · $25.32M
  • DXCM DEXCOM INC · $24.77M
  • COO COOPER COS INC · $20.77M
  • COR CENCORA INC · $17.43M
  • THC TENET HEALTHCARE CORP · $14.90M
  • HCA HCA HEALTHCARE INC · $13.81M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest Parkman Healthcare Partners LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Parkman Healthcare Partners LLC, based in Stamford, CT, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 77 positions worth $976.83M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: STAMFORD, CT, United States
  • SEC registration: 801-114849 (status: Approved), registered 2019-03-15
  • Regulatory AUM (Form ADV): $1.74B as of 2026-03-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds

Portfolio Structure

  • 77 positions · $976.83M reported value (Q2 2026)
  • Top 10 holdings = 33.5% of reported value
  • Largest position: MBX (MBX BIOSCIENCES INC COM) at 4.5%
  • Average position size: $12.69M

Sector Tilt

  • Health Care 92.1%
  • Consumer Staples 4.1%
  • Industrials 3.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 18 new, 25 added, 30 reduced, 31 exited
  • 4 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 78.5%
Other 18.6%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 597.26K $31.54M 5.78%
5.78%
New
2 138.33K $31.24M 5.72%
5.72%
New
3 97.95K $25.32M 4.64%
4.64%
New
4 265.52K $24.77M 4.54%
4.54%
New
5 65.32K $20.77M 3.81%
3.81%
New
6 96.84K $17.43M 3.19%
3.19%
New
7 226.14K $14.90M 2.73%
2.73%
New
8 56.16K $13.81M 2.53%
2.53%
New
9 238.13K $12.14M 2.22%
2.22%
New
10 717.92K $11.39M 2.09%
2.09%
New
11 381.33K $10.64M 1.95%
1.95%
New
12 368.65K $10.42M 1.91%
1.91%
New
13 21.31K $10.37M 1.90%
1.90%
New
14 298.48K $9.52M 1.74%
1.74%
New
15 83.84K $9.43M 1.73%
1.73%
New
16 509.81K $8.86M 1.62%
1.62%
New
17 51.31K $8.68M 1.59%
1.59%
New
18 44.16K $8.65M 1.59%
1.59%
New
19 2.07M $8.54M 1.57%
1.57%
New
20 88.96K $7.97M 1.46%
1.46%
New
21 71.00K $7.97M 1.46%
1.46%
New
22 15.33K $7.76M 1.42%
1.42%
New
23 597.40K $7.60M 1.39%
1.39%
New
24 216.64K $7.40M 1.36%
1.36%
New
25 203.48K $7.30M 1.34%
1.34%
New
26 159.50K $7.24M 1.33%
1.33%
New
27 417.93K $6.81M 1.25%
1.25%
New
28 42.02K $6.70M 1.23%
1.23%
New
29 111.80K $6.49M 1.19%
1.19%
New
30 116.11K $5.87M 1.08%
1.08%
New
31 466.41K $5.72M 1.05%
1.05%
New
32 363.55K $5.61M 1.03%
1.03%
New
33 20.00K $5.38M 0.98%
0.98%
New
34 26.92K $5.34M 0.98%
0.98%
New
35 577.49K $5.16M 0.95%
0.95%
New
36 225.87K $5.04M 0.92%
0.92%
New
37 1.75M $4.36M 0.80%
0.80%
New
38 1.18M $4.10M 0.75%
0.75%
New
39 438.75K $3.97M 0.73%
0.73%
New
40 138.17K $3.81M 0.70%
0.70%
New
41 224.59K $3.79M 0.69%
0.69%
New
42 249.34K $3.74M 0.69%
0.69%
New
43 205.11K $3.68M 0.68%
0.68%
New
44 80.65K $3.67M 0.67%
0.67%
New
45 132.70K $3.58M 0.66%
0.66%
New
46 49.89K $3.47M 0.64%
0.64%
New
47 222.12K $3.37M 0.62%
0.62%
New
48 155.05K $3.29M 0.60%
0.60%
New
49 125.00K $3.16M 0.58%
0.58%
New
50 212.45K $3.08M 0.56%
0.56%
New

FAQ

What did Parkman Healthcare Partners LLC buy in 2023-Q3?

In its 2023-Q3 13F filing, Parkman Healthcare Partners LLC reported 102 equity positions worth $545.76M in aggregate; its largest disclosed positions were BSX ($31.54M), UTHR ($31.24M), BDX ($25.32M).

How large is Parkman Healthcare Partners LLC's portfolio?

Parkman Healthcare Partners LLC reported $545.76M of long equity holdings across 102 positions as of 2023-Q3. Top-10 holdings account for 37.3% of reported value.

What is Parkman Healthcare Partners LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/parkman-healthcare-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →